Protective effects of quinic acid derivatives on tetrahydropapaveroline- induced cell death in C6 glioma cells

Biological and Pharmaceutical Bulletin

Volumn 26, Issue 6, 2003, Pages 803-807

  Soh, Yunjo ^a   Kim, Ji Ae ^a   Sohn, Nak Won ^a   Kang, Ro Lee ^b   Sun, Yeou Kim ^a  

^a Kyung Hee University   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Antioxidant enzyme; Quinic acid; Tetrahydropapaveroline

Indexed keywords

3,4 DICAFFEOYLQUINIC ACID; CATALASE; GLUTATHIONE PEROXIDASE; HOE 33342; MALONALDEHYDE; PROPIDIUM IODIDE; QUINIC ACID; SUPEROXIDE DISMUTASE; TETRAHYDROPAPAVEROLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTERACEAE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; ENZYME ACTIVITY; GLIOMA CELL; NONHUMAN; OXIDATIVE STRESS; RAT;

EID: 10644287723     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.26.803     Document Type: Article

References (23)

1. Nagao T., Okabe H., Chem. Pharm. Bull., 40, 886-888 (1992).
2. Nagao T., Tanaka R., Iwase Y., Okabe H., Chem Pharm. Bull., 41, 659-665 (1993).
3. Jung C. M., Kwon H. C., Seo J. J., Ohizumi Y., Matsunaga K., Saito S., Lee K. R., Chem Pharm Bull., 49, 912-914 (2001).
4. Kwon H. C , Jung C. M , Shin C. G., Lee J. K., Choi S. U., Kim S. Y., Lee K. R., Chem. Pharm Bull , 48, 1796-1798 (2000).
5. Hur J. Y., Soh Y., Kim B. H., Suk K., Sohn N. W., Kim H. C., Kwon H. C., Lee K. R., Kim S. Y., Biol. Pharm. Bull., 24, 921-924 (2001).
6. Davis V E , Walsh M. J., Science, 167, 1005-1007 (1970).
7. Holtz P., Stock K., Westermann E., Nature (London), 203, 656-658 (1964).
8. Cashaw J. L., Geraghty C. A., McLaughlin B. R., Davis V. E., J. Neurosci Res., 18, 497-503 (1987).
9. Morikawa N., Nakagawa-Hattori Y., Mizuno Y., J. Neurochem., 56, 1174-1181 (1996).
10. Sandler M., Carter S. B., Hunter K. R., Stern G. M., Nature (London), 241, 439-443 (1973).
11. Kim H J., Soh Y., Jang J. H., Lee J. S., Oh Y. J., Surh Y. J., Mol Pharmacol., 60, 440-449 (2001).
12. Surh Y., Eur. J. Clin. Invest., 29, 650-651 (1999).
13. Collins M. A., Trends Pharmacol. Sci., 3, 373-375 (1982).
14. Okada T., Shimada S., Sato K., Kotake Y., Kawai H., Ohta S., Tohyama M., Nishimura T., Neurosci Res., 30, 87-90 (1998).
15. Brismar T., Glia, 15, 231-243 (1995)
16. Soh Y., Jeong K. S., Lee I. J., Bae M. A., Kim Y. C., Song B. J., Mol. Pharmacol., 58, 535-541 (2000).
17. Mosmann T., J. Immunol. Method, 65, 55-63 (1983).
18. Claiborne A., Fridovich I., J. Biol. Chem , 254, 4245-4252 (1979).
19. Oyanagui Y., Anal. Biochem., 142, 290-296 (1984).
20. Yoshida T., Mori K., Hatano T., Okumura T., Uehara I., Komagoe K., Okuda T., Chem. Pharm. Bull., 379, 1919-1921 (1989).
21. Kim H. J., Lee W. H., Yoon C. H., Jeong J. C., Nam K. S., Kim H. M., Choo Y K., Lee M. C., Kim C. H., Pharmacol Res , 43, 11-16 (2001).
22. Xiao X. Q., Wang R., Han Y. F., Tang X. C., Neurosci Lett., 286, 155-158 (2000)
23. Maruyama W., Sango K., Iwasa K., Minami C., Dostert P., Kawai M., Moriyasu M., Naoi M., Neurosci Lett , 291, 89-92 (2000).